Most patients notice changes in body composition between weeks 4 and 8 of a structured cycle
Provides gastroprotective effects against damage from NSAIDs and other medications that commonly irritate the digestive tract, supporting safe long-term pharmaceutical use when medically necessary
Per FDA guidance, GLP-1-based medications are generally approved for adults with a BMI over 30, or over 27 with a qualifying health condition such as type 2 diabetes, high blood pressure, or high cholesterol
This method allows for absorption through the oral mucosa, bypassing some digestive breakdown and providing moderate systemic availability
Many protocols recommend washing with gentle cleanser and allowing complete drying before the microneedling session
Metabolic B12 deficiency is prevalent, impacting 10%-40% of the population